Volume 8; Issue 12

Main
The Lancet Neurology
Volume 8; Issue 12

The Lancet Neurology

Volume 8; Issue 12

1

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

Dennis W Dickson, Heiko Braak, John E Duda, Charles Duyckaerts, Thomas Gasser, Glenda M Halliday, John Hardy, James B Leverenz, Kelly Del Tredici, Zbigniew K Wszolek, Irene Litvan

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 555 KB

english, 2009

2

Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study

Neil A Goldenberg, Timothy J Bernard, Heather J Fullerton, Anne Gordon, Gabrielle deVeber

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 347 KB

english, 2009

3

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

Joëlle Micallef, Shahram Attarian, Odile Dubourg, Pierre-Marie Gonnaud, Jean-Yves Hogrel, Tanya Stojkovic, Rafaelle Bernard, Elisabeth Jouve, Severine Pitel, Francois Vacherot, Jean-Francois Remec, La

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 169 KB

english, 2009

4

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

Erich Bluhmki, Ángel Chamorro, Antoni Dávalos, Thomas Machnig, Christophe Sauce, Nils Wahlgren, Joanna Wardlaw, Werner Hacke

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 296 KB

english, 2009

5

Challenges in childhood arterial ischaemic stroke

M Patricia Massicotte, Mary E Bauman, Greg W Albers

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 67 KB

english, 2009

6

Charcot–Marie–Tooth disease type 1A: is ascorbic acid effective?

Davide Pareyson, Alessandra Solari

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 217 KB

english, 2009

7

Can we predict multiple sclerosis?

Sreeram V Ramagopalan, Gavin Giovannoni

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 63 KB

english, 2009

8

Extending the time window for thrombolytic therapy—primum non tardare

Patrick D Lyden

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 159 KB

english, 2009

9

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

Philip L De Jager, Lori B Chibnik, Jing Cui, Joachim Reischl, Stephan Lehr, K Claire Simon, Cristin Aubin, David Bauer, Jürgen F Heubach, Rupert Sandbrink, Michaela Tyblova, Petra Lelkova, Eva Havrdov

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 246 KB

english, 2009

10

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

Valerie Voon, Pierre-Olivier Fernagut, Jeff Wickens, Christelle Baunez, Manuel Rodriguez, Nancy Pavon, Jorge L Juncos, José A Obeso, Erwan Bezard

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 130 KB

english, 2009

11

Multiple system atrophy: an update

Nadia Stefanova, Philipp Bücke, Susanne Duerr, Gregor Karl Wenning

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 160 KB

english, 2009

12

Progression of Parkinson's disease in the clinical phase: potential markers

Walter Maetzler, Inga Liepelt, Daniela Berg

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 233 KB

english, 2009

13

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

Maria C Rodriguez-Oroz, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl Macias, Erwan Bezard, José A Obeso

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 666 KB

english, 2009

14

ADAGIO misses a beat?

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 59 KB

english, 2009

15

Alzheimer's disease: a global challenge for the 21st century

Jean François Dartigues

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 53 KB

english, 2009

16

Movement disorders research: a new decade of cooperation

The Lancet Neurology

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 37 KB

english, 2009

17

Erratum

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 46 KB

english, 2009

18

Treatment of basilar artery occlusion: a prospective randomised therapeutic study is needed

Gernot Schulte-Altedorneburg, Thomas Liebig, Hartmut Brückmann, Olav Jansen

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 77 KB

english, 2009

19

Treatment of basilar artery occlusion: a prospective randomised therapeutic study is needed – Authors' reply

Wouter J Schonewille, Christine AC Wijman, L Jaap Kappelle, Ale Algra

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 70 KB

english, 2009

20

Do interferon beta-1b and glatiramer acetate grow brain?

Richard A Rudick, Elizabeth Fisher

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 78 KB

english, 2009

21

Do interferon beta-1b and glatiramer acetate grow brain? – Authors' reply

Massimo Filippi, Paul O'Connor

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

22

For neurologists in Cuba, hope is not embargoed

Elena Becker-Barroso

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 391 KB

english, 2009

23

Anthony Lang: master of movement disorders

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 72 KB

english, 2009

24

September, 2009

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 75 KB

english, 2009

25

Maria C Rodriguez-Oroz

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 75 KB

english, 2009

26

The nuts and bolts of neuroscience trials

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 73 KB

english, 2009

27

Olfaction and its impact for clinicians

Basile N Landis

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 101 KB

english, 2009

28

An ocean in a nutshell

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 101 KB

english, 2009

29

News in brief

Journal:

The Lancet Neurology

Year:

2009

Language:

english

File:

PDF, 153 KB

english, 2009